Graham Capital Management, L.P. Amneal Pharmaceuticals, Inc. Transaction History

Graham Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.36 - $6.21 $74,141 - $137,029	22,066 New	22,066 $133,000
Q2 2023 Aug 14, 2023	BUY	$1.33 - $3.1 $12,031 - $28,042	9,046 Added 42.98%	30,092 $93,000
Q1 2023 May 15, 2023	SELL	$1.27 - $2.7 $652,504 - $1.39 Million	-513,783 Reduced 96.06%	21,046 $29,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $1.05 Million - $1.4 Million	534,829 New	534,829 $1.06 Million
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $311,631 - $461,752	-103,532 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $403,774 - $506,271	103,532 New	103,532 $431,000

183

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.21B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.